Related Experiment Video

Updated: Aug 9, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Monotherapy with labetalol for hypertensive patients with normal and impaired renal function

F D Thompson, A M Joekes, M M Hussein

    British Journal of Clinical Pharmacology
    |January 1, 1979
    PubMed

    Insights

    Labetalol effectively treated hypertension in patients with essential and renal hypertension, showing a rapid hypotensive response without causing adverse effects on renal function or blood pressure during activity.

    Area of Science:

    • Pharmacology
    • Cardiology
    • Nephrology

    Background:

    • Hypertension remains a significant global health concern.
    • Effective antihypertensive medications are crucial for managing blood pressure and preventing complications.
    • Labetalol, a combined alpha- and beta-blocker, offers a unique mechanism for blood pressure control.

    Purpose of the Study:

    • To evaluate the efficacy and safety of labetalol in hypertensive patients.
    • To assess labetalol's effectiveness in different types of hypertension (essential and renal).
    • To determine the onset of action and potential side effects of labetalol.

    Main Methods:

    • A study involving 41 hypertensive patients.
    • Labetalol administered in divided daily doses (150–2,400 mg) for 1–64 months.
    • Assessment of hypotensive response after a single 200 mg oral dose.
    • Monitoring for exercise/postural hypotension and renal function changes.

    Main Results:

    • Labetalol monotherapy was effective in 12/19 essential hypertension and 15/22 renal hypertension patients.
    • A hypotensive response was observed 1.5–2 hours after a 200 mg oral dose.
    • No exercise or postural hypotension was noted at the doses used.
    • No reduction in overall renal function was attributed to labetalol.

    Conclusions:

    • Labetalol is an effective monotherapy for both essential and renal hypertension.
    • Labetalol demonstrates a predictable onset of action and a favorable safety profile.
    • The drug does not appear to compromise renal function or cause orthostatic/exercise-induced hypotension.

    More Related Videos

    The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension05:57

    The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

    Published on: May 17, 2024

    Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension04:37

    Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

    Published on: June 6, 2025

    Related Concept Videos

    Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

    Adrenergic Antagonists: ɑ and β-Receptor Blockers

    Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
    Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

    Antihypertensive Drugs: Potassium-Sparing Diuretics

    Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    Renal Failure: Dose Adjustments01:11

    Renal Failure: Dose Adjustments

    In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
    Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
    However, dosage adjustments...
    Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

    Hypertension III: Clinical Manifestations and Diagnostic Studies

    Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
    Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

    Hypertension IV: Drug Therapy and Lifestyle Modifications

    Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...